Exclusive: Renowned immunology leader 'Skip' Virgin is out as Altos Labs medical chief

13 Dec 2023

Executive Change

Herbert “Skip” Virgin is no longer the chief medical officer at Hal Barron and Rick Klausner’s $3 billion anti-aging startup Altos Labs, just a little over a year after the renowned immunology researcher took on the role, he confirmed to Endpoints News via email. Virgin, a researcher with decades of experience in immunology, was also the head of Altos Institute of Medicine. The sprawling but quiet startup also has three institutes of science in San Diego, the Bay Area and Cambridge, UK. Aside from a massive pool of money, the cellular rejuvenation company also has a star-studded board, which includes Nobel laureates like Frances Arnold and CRISPR pioneer Jennifer Doudna.

For more details,please visit the original website

The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.

Organizations

Altos Labs, Inc.

Indications

Targets

Drugs

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.